Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles-mumps-rubella or a diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis vaccine mixed with a Haemophilus influenzae type b conjugate vaccine in infants aged 12-18 months

Vaccine

Volumn 23, Issue 20, 2005, Pages 2602-2606

  Usonis, V ^a   Meriste, S ^b   Bakasenas, V ^c   Lutsar, I ^b   Collard, F ^d   Stoffel, M ^d   Tornieporth, N ^d  

^a VILNIUS UNIVERSITY   (Lithuania)

^b Tartu University Children's Hospital   (Estonia)

^c Centre for Communicable Diseases Prevention and Control   (Lithuania)

^d GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Concomitant vaccination; DTPa IPV Hib; Hepatitis A B vaccine; MMR

Indexed keywords

DIPHTHERIA ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A ANTIBODY; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN; INACTIVATED VIRUS VACCINE; MEASLES ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; POLIOMYELITIS VACCINE; RUBELLA ANTIBODY; TETANUS ANTIBODY; VIRUS ANTIBODY;

ANOREXIA; ANTIBODY TITER; ARTICLE; DROWSINESS; DRUG SAFETY; DRUG TOLERABILITY; FEBRILE CONVULSION; FEMALE; FEVER; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INFANT; INJECTION SITE REACTION; IRRITABILITY; MALE; NORMAL HUMAN; PAIN; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; SEROLOGY; SIDE EFFECT; SKIN EDEMA; TREATMENT OUTCOME; VACCINATION; VOMITING;

EID: 15044366266     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.11.062     Document Type: Article

References (12)

1. F.E. André Development and clinical application of new polyvalent combined paediatric vaccines Vaccine 17 1999 1620 1627
2. S.A. Halperin Developing better paediatric vaccines BioDrugs 12 3 1999 175 191
3. V. Usonis, V. Bakasenas, A. Kaufhold, K. Chitour, and R. Clemens Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in children Pediatr Infect Dis J 18 1 1999 42 48
4. P. Crovari, G. Gabutti, G. Giammanco, P. Dentico, A.R. Moiraghi, F. Ponzio The Cooperative Group for the Study of MMR Vaccines Reactogenicity and immunogenicity of a new combined Measles-Mumps-Rubella vaccine: results of a multicentre trial Vaccine 18 25 2000 2796 2803
5. World Health Organization. Informal consultation on quadrivalent diphtheria, tetanus, pertusissis, hepatitis B vaccine. Final Report. Geneva: WHO, 1992: 1-12.
6. R. Dagan, K. Igbaria, L. Piglansky, and R. Melamed Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilis influenzae type b-tetanus conjugate vaccine compared with a whole cell pertussis pentavalent vaccine Pediatr Infect Dis J 16 12 1997 1113 1121
7. S. Meriste, E. Tamm, P. Willems, and I. Lutsar Safety and immunogenicity of combined DTPa-IPV vaccine for primary and booster vaccination Scand J Infect Dis 31 6 1999 587 591
8. M. Van der Wielen, P. Van Damme, and F. Collard A two dose schedule for combined hepatitis A and hepatitis B vaccination in children aged 1-11 years Pediatr Infect Dis J 19 9 2000 848 853
9. V. Usonis, V. Bakasenas, K. Chitour, and R. Clemens Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and Rubella vaccines in healthy children Infection 26 4 1998 222 226
10. S.A. Halperin, J.B. King, E. Mills, and P. Willems Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses Clin Infect Dis 28 5 1999 995 1001
11. D. Roberton, H. Marshall, T.M. Nolan, and E. Sokal Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children Proceedings of the 43rd Intersci Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Chicago 2003 296
12. H.H. Bernstein, E.P. Rothstein, K.S. Reisinger, and M.M. Blatter Comparison of a three-component acellular pertussis vaccine with a whole cell pertussis vaccine in 15-through 20-month-old infants Pediatrics 93 4 1994 656 659